The prediction of intraoperative cervical cord function changes by different motor evoked potentials phenotypes in cervical myelopathy patients.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
30 May 2020
Historique:
received: 05 12 2019
accepted: 19 05 2020
entrez: 1 6 2020
pubmed: 1 6 2020
medline: 23 9 2020
Statut: epublish

Résumé

Surgery is usually the treatment of choice for patients with cervical compressive myelopathy (CCM). Motor evoked potential (MEP) has proved to be helpful tool in evaluating intraoperative cervical spinal cord function change of those patients. This study aims to describe and evaluate different MEP baseline phenotypes for predicting MEP changes during CCM surgery. A total of 105 consecutive CCM patients underwent posterior cervical spine decompression were prospectively collected between December 2012 and November 2016. All intraoperative MEP baselines recorded before spinal cord decompression were classified into 5 types (I to V) that were carefully designed according to the different MEP parameters. The postoperative neurologic status of each patient was assessed immediately after surgery. The mean intraoperative MEP changes range were 10.2% ± 5.8, 14.7% ± 9.2, 54.8% ± 31.9, 74.1% ± 24.3, and 110% ± 40 in Type I, II, III, IV, and V, respectively. There was a significant correlation of the intraoperative MEP change rate with different MEP baseline phenotypes (r = 0.84, P < 0.01). Postoperative transient new spinal deficits were found 0/31 case in Type I, 0/21 in Type II, 1/14 in Type III, 2/24 in Type IV, and 4/15 in Type V. No permanent neurological injury was found in our cases series. The MEP baselines categories for predicting intraoperative cervical cord function change is proposed through this work. The more serious the MEP baseline abnormality, the higher the probability of intraoperative MEP changes, which is beneficial to early warning for the cervical cord injury.

Sections du résumé

BACKGROUND BACKGROUND
Surgery is usually the treatment of choice for patients with cervical compressive myelopathy (CCM). Motor evoked potential (MEP) has proved to be helpful tool in evaluating intraoperative cervical spinal cord function change of those patients. This study aims to describe and evaluate different MEP baseline phenotypes for predicting MEP changes during CCM surgery.
METHODS METHODS
A total of 105 consecutive CCM patients underwent posterior cervical spine decompression were prospectively collected between December 2012 and November 2016. All intraoperative MEP baselines recorded before spinal cord decompression were classified into 5 types (I to V) that were carefully designed according to the different MEP parameters. The postoperative neurologic status of each patient was assessed immediately after surgery.
RESULTS RESULTS
The mean intraoperative MEP changes range were 10.2% ± 5.8, 14.7% ± 9.2, 54.8% ± 31.9, 74.1% ± 24.3, and 110% ± 40 in Type I, II, III, IV, and V, respectively. There was a significant correlation of the intraoperative MEP change rate with different MEP baseline phenotypes (r = 0.84, P < 0.01). Postoperative transient new spinal deficits were found 0/31 case in Type I, 0/21 in Type II, 1/14 in Type III, 2/24 in Type IV, and 4/15 in Type V. No permanent neurological injury was found in our cases series.
CONCLUSIONS CONCLUSIONS
The MEP baselines categories for predicting intraoperative cervical cord function change is proposed through this work. The more serious the MEP baseline abnormality, the higher the probability of intraoperative MEP changes, which is beneficial to early warning for the cervical cord injury.

Identifiants

pubmed: 32473653
doi: 10.1186/s12883-020-01799-w
pii: 10.1186/s12883-020-01799-w
pmc: PMC7261380
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

221

Références

J Neurol Sci. 1998 Feb 5;154(2):222-8
pubmed: 9562314
Spine (Phila Pa 1976). 1989 Oct;14(10):1078-83
pubmed: 2588056
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):104-6
pubmed: 8429310
Brain Res. 1992 Oct 16;593(2):159-67
pubmed: 1450926
Spine (Phila Pa 1976). 1999 Mar 1;24(5):455-61; discussion 462
pubmed: 10084183
Spine (Phila Pa 1976). 2007 Mar 15;32(6):E197-202
pubmed: 17413460
Neurosurg Focus. 2013 Jul;35(1):E7
pubmed: 23815252
J Neurosurg Spine. 2014 Aug;21(2):210-6
pubmed: 24855997
Spine (Phila Pa 1976). 2001 Jul 1;26(13):E294-9
pubmed: 11458169
World Neurosurg. 2018 Jul;115:e738-e747
pubmed: 29729461
J Neurosurg. 1998 Mar;88(3):457-70
pubmed: 9488299
Spine (Phila Pa 1976). 2015 Jul 15;40(14):1092-100
pubmed: 25893357
Eur Spine J. 2016 Jun;25(6):1875-80
pubmed: 26951171
Spine (Phila Pa 1976). 2008 May 1;33(10):1100-6
pubmed: 18449044
Clin Neurophysiol. 2008 Feb;119(2):248-64
pubmed: 18053764
J Neurosurg Anesthesiol. 2018 Jan;30(1):39-43
pubmed: 27851693
Spine J. 2008 Jul-Aug;8(4):645-9
pubmed: 18586200
Spine (Phila Pa 1976). 2015 Feb 1;40(3):171-8
pubmed: 25668335
J Clin Neurosci. 2010 Feb;17(2):274-6
pubmed: 20006509
Eur Spine J. 2015 Dec;24(12):2941-5
pubmed: 26155898
Anesth Analg. 2016 Mar;122(3):706-11
pubmed: 26599796
Spine (Phila Pa 1976). 2012 Jul 1;37(15):E913-21
pubmed: 22322375
J Clin Neurophysiol. 2014 Dec;31(6):568-74
pubmed: 25462144
Spine (Phila Pa 1976). 2016 Mar;41(6):470-5
pubmed: 26966972
Spine J. 2014 Jul 1;14(7):1214-20
pubmed: 24200409
Spine (Phila Pa 1976). 2016 Sep;41(17):1387-93
pubmed: 26913466
Spine (Phila Pa 1976). 2013 Mar 1;38(5):392-400
pubmed: 23448898
Spine (Phila Pa 1976). 2007 Dec 15;32(26):3041-6
pubmed: 18091499
Spine (Phila Pa 1976). 1995 Oct 15;20(20):2240-6
pubmed: 8545719
Spine J. 2013 Sep;13(9):1077-9
pubmed: 23562331
Spine J. 2014 Aug 1;14(8):1601-10
pubmed: 24411833
Spine (Phila Pa 1976). 2019 Apr 15;44(8):E470-E479
pubmed: 30312271
Spine (Phila Pa 1976). 2014 Feb 1;39(3):E159-65
pubmed: 24153163
Spine J. 2017 Jun;17(6):777-783
pubmed: 26475414
Eur Spine J. 2017 Sep;26(9):2404-2409
pubmed: 28620788
Acta Neurochir (Wien). 2014 Apr;156(4):723-31
pubmed: 24452593
Clin Spine Surg. 2016 Dec;29(10):E496-E501
pubmed: 27171661
J Pediatr Orthop. 2010 Sep;30(6):624-8
pubmed: 20733431
J Bone Joint Surg Am. 2004 Jun;86(6):1248-53
pubmed: 15173299
Spine (Phila Pa 1976). 1993 Oct 15;18(14):2024-9
pubmed: 8272953
Spine (Phila Pa 1976). 2010 Dec 1;35(25):2167-79
pubmed: 21102290
Spine (Phila Pa 1976). 2013 Oct 15;38(22 Suppl 1):S89-110
pubmed: 23962996
Spine (Phila Pa 1976). 1988 Oct;13(10):1119-24
pubmed: 3206268
Spine (Phila Pa 1976). 2008 May 1;33(10):E305-10
pubmed: 18449030
Spine (Phila Pa 1976). 1997 May 1;22(9):1013-7
pubmed: 9152452
Clin Neurophysiol. 2013 Dec;124(12):2291-316
pubmed: 24055297

Auteurs

Shujie Wang (S)

Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 1 Shuai Fu Yuan, Beijing, 100730, PR China.

Zhifu Ren (Z)

Department of Spine Surgery, Municipal Traditional Chinese Hospital, Weifang, Shandong, 261041, PR China.

Jia Liu (J)

China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.

Jianguo Zhang (J)

Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 1 Shuai Fu Yuan, Beijing, 100730, PR China.

Ye Tian (Y)

Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 1 Shuai Fu Yuan, Beijing, 100730, PR China. pumchtianye@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH